Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 14,210,000 $ 4,301,000
Restricted cash   3,025,000
Subscription receivable   204,000
Promissory note receivable and accrued interest 713,000  
Prepaid expenses and other current assets 749,000 664,000
Current assets held for sale (see Note 3 - Discontinued Operations)   18,065,000
Total Current Assets 15,672,000 26,259,000
Restricted cash 215,000 253,000
Promissory note receivable 1,081,000 1,706,000
Finance lease right-of-use assets, net of accumulated amortization 339,000 610,000
Operating lease right-of-use asset 2,401,000 2,722,000
Fixed assets, net of accumulated depreciation 3,632,000 4,219,000
Intangible assets, net of accumulated amortization 5,368,000 5,388,000
Security deposits 26,000 50,000
Total Assets 28,734,000 41,207,000
Current liabilities:    
Accounts payable 358,000 1,849,000
Accrued expenses 2,028,000 4,561,000
Finance lease obligations - current portion 299,000 272,000
Operating lease obligation - current portion 436,000 389,000
Equipment financing payable - current portion 178,000 160,000
Term promissory note - current portion 218,000  
Insurance premium financing payable 123,000  
Term note payable - net of deferred financing costs   12,937,000
Contract liabilities 200,000 0
Current liabilities related to assets held for sale   1,941,000
Total Current Liabilities 3,840,000 22,109,000
Finance lease obligations - net of current portion 53,000 351,000
Operating lease obligation - net of current portion 2,688,000 3,125,000
Equipment financing payable - net of current portion 63,000 241,000
Term promissory note - net of current portion 766,000  
Total Liabilities 7,410,000 25,826,000
Stockholders' Equity    
Series 2022 Convertible Preferred Stock - $0.001 par value; 1,000,000 shares authorized at June 30, 2024 and June 30, 2023; 0 shares issued and outstanding as of June 30, 2024 and June 30, 2023, respectively 0 0
Common Stock - $0.001 par value; 275,000,000 shares authorized at June 30, 2024 and June 30, 2023; 8,623,676 and 1,015,505 shares issued and outstanding as of June 30, 2024 and June 30, 2023, respectively 9,000 1,000
Additional paid-in capital 335,162,000 304,320,000
Accumulated deficit (313,847,000) (288,940,000)
Total Stockholders' Equity 21,324,000 15,381,000
Total Liabilities and Stockholders' Equity $ 28,734,000 $ 41,207,000